TLSI
Trisalus Life Sciences
$4.32
+$0.10 (+2.37%)Jul 27, 2026
Key metrics
The numbers that frame TLSI today
- Market cap
- $265.32M
- P/E (TTM)
- -9.7
- EV / FCF
- -12.0
- Gross margin
- 85.1%
- EV / Sales
- 5.4
- ROIC
- -57%
- Div yield
- 0%
- Debt / equity
- 2.7
- 52wk Low
- $2.20
- 52wk High
- $7.95
Growth
Revenue and earnings trend for TLSI
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TLSI
Is Trisalus Life Sciences a good buy?
No. Trisalus Life Sciences has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Trisalus Life Sciences is selling at a very high price.
What is the market capitalization of TLSI?
Trisalus Life Sciences's market capitalization is $265.32M.
What is the P/E ratio for TLSI stock?
Trisalus Life Sciences's current P/E ratio is -9.7.
What is the 52-week high for TLSI stock?
The 52-week high for Trisalus Life Sciences is $7.95. The current close of $4.32 is 45.7% below that high.
What is the 52-week low for TLSI stock?
The 52-week low for Trisalus Life Sciences is $2.20. The current close of $4.32 is 96.4% above that low.
Does TLSI stock pay dividends?
Trisalus Life Sciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TLSI?
Trisalus Life Sciences's Debt / Equity ratio is 2.69.